RecruitingPhase 2

Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic

Tunisia1,500 participantsStarted 2024-04-10

Plain-language summary

This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * -Age \> 18 years old. * Consent to participate in the study. * Pain in the flank/lumbar fossa of sudden onset with urine strips and/or imaging corresponding to the diagnosis of renal colic. * Pain score at discharge \< 30 (visual analog scale - VAS or verbal numerical scale - VAS from 0 to 100). Exclusion Criteria: * -Inability to appreciate pain according to the VAS. * Pregnant or breastfeeding woman. * Renal insufficiency with creatinine clearance \< 60 ml/min.

What they're measuring

Recurrence of RC and ED readmission

Timeframe: 7 day after inclusion

Trial details

NCT IDNCT06345716

SponsorUniversity of Monastir

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-15

Contact for this trial

Khaoula Bel Haj Ali

99792724 belhajalikhaoula@yahoo.fr

View on ClinicalTrials.gov More Renal Colic trials